Hanwha Buspirone Tablets 5 mg (Buspirone Hydrochloride)

Adult dose

Adults: The initial dose is 5mg of buspirone hydrochloride orally 3 times daily. If necessary, to achieve an adequate therapeutic response, it is preferable to increase the daily dose by 5mg at intervals of 2-3 days, to 20-30mg daily in divided doses. The total daily dose should not exceed 60mg. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in certain patients. For example, it should not be administered to individuals who are allergic to it, have severe liver or kidney problems, suffer from epilepsy, have acute glaucoma, have severe myasthenia gravis, or are taking MAO inhibitors. Additionally, this medication contains lactose and should not be used by patients with lactose intolerance or certain genetic issues. Caution is needed when taking this medication as various side effects may occur. For instance, cardiovascular symptoms such as chest pain, fainting, and changes in blood pressure may occur, while central nervous system symptoms may include drowsiness, dizziness, insomnia, hallucinations, and suicidal thoughts. Abnormal symptoms may also appear in the eyes, ears, nose, and throat, and digestive system effects may include appetite changes, abdominal bloating, and nausea. Various side effects affecting different organs have been reported, so any abnormal symptoms should be reported to a doctor immediately. This medication is not used as an antipsychotic, and patient reactions can be unpredictable, so driving or operating dangerous machinery should be avoided. Patients with dependence on sedatives or sleeping pills should not seek to relieve withdrawal symptoms with this medication and should gradually reduce their previous medications. Additionally, as this medication may affect dopamine receptors, caution is necessary as anxiety or movement disorders may occur. When taken with other central nervous system medications, there may be a possibility of interactions, so caution is advised, and co-administration with alcohol is not recommended. Particularly, concurrent use with MAO inhibitors must be avoided due to a potential increase in blood pressure. Women who are pregnant or may become pregnant should consult with a physician before taking this medication as its safety has not been established, and it is advisable to avoid using this medication while breastfeeding. The safety and efficacy of this medication have not been established in individuals under 18 years of age, so it should not be used in this population. In cases of overdose, nausea, vomiting, dizziness, and drowsiness may occur, but no fatalities have been reported; symptomatic treatment such as gastric lavage should be conducted, and the patient's condition should be monitored continuously. Finally, it is important to inform the physician about any other medications currently being taken or alcohol consumption while taking this medication, and careful observation is required for those with a history of substance abuse.

• Non-specific chest pain
• fainting
• hypertension
• hypotension
• cerebrovascular disease
• congestive heart failure
• myocardial infarction
• cardiomyopathy
• bradycardia
• sleep disorders

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White oval-shaped tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle